ArticleCancer research communications2026

OB-001 Enhances Osimertinib Brain Penetration: Preclinical Pharmacokinetics and Translational Rationale for EGFR-Mutant NSCLC with CNS Disease.

Hitesh B Mistry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.